Precise medical decision making in geriatric anti-depressant therapy

References

• World Health Organization. Depression. A Global Public Health Concern. 2012. [cited 2016 Mar 18] Available from: http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf
   Google Scholar
• World Health Organization. The global burden of disease: 2004 update. 2004. [cited 2016 Mar 18] Available from: http://www.who.int/entity/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf
   Google Scholar
• Lépine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3–7.
   PubMedGoogle Scholar
• Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:435–451.
   PubMed Web of Science ®Google Scholar
• Hamon M, Blier P. Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45C:54–63.
   Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095.
   PubMed Web of Science ®Google Scholar
• Simon G, Ciechanowski P. Patient information: depression treatment options for adults (Beyond the basics). UpToDate, Roy-Byrne P, editors. Waltham (MA): UpToDate; [cited 2016 Mar 24]. 2015. Available from: http://www.uptodate.com/contents/depression-treatment-options-for-adults-beyond-the-basics
   Google Scholar
• Kok RM, Nolen WA, Heeren TJ. Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord. 2012;141:103–115.
   PubMed Web of Science ®Google Scholar
• De Las Cuevas C, Peñate W, Sanz EJ. Risk factors for non-adherence to antidepressant treatment in patients with mood disorders. Eur J Clin Pharmacol. 2014;70:89–98.
   PubMed Web of Science ®Google Scholar
• Woolley SB, Fredman L, Goethe JW, et al. Hospital patients’ perceptions during treatment and early discontinuation of serotonin selective reuptake inhibitor antidepressants. J Clin Physhopharmacol. 2010;30(6):716–719.
   PubMed Web of Science ®Google Scholar
• Ereshefsky L, Saragoussi D, Despiegel N, et al. The 6-month persistence on SSRIs and associated economic burden. J Econ. 2010;13:527–536.
   Google Scholar
• Serna MC, Real J, Cruz I, et al. Monitoring patients on chronic treatment with antidepressants between 2003 and 2011: analysis of factors associated with compliance. BMC Public Health. 2015;15:1184.
   PubMed Web of Science ®Google Scholar
• Toronto: Canadian Coalition for Seniors’ Mental Health. National guidelines for seniors’ mental health: the assessment and treatment of depression 2006 [cited 2016 Mar 24], Available from: http://www.ccsmh.ca/en/natlguidelines/depression.cfm
   Google Scholar
• Dennis M, Kadri A, Coffey J. Depression in older people in the general hospital: a systematic review of screening instruments. Age Ageing. [Internet]. 2012;41(2):148–154. [updated 2016 March 18; cited 2015 Aug 17]. Available from: http://ageing.oxfordjournals.org/content/41/2/148.full.pdf+html
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Wang X, Castle NG, et al. Potential underuse, overuse and inappropriate use of antidepressants in older veteran nursing home patients. J Am Geriatr Soc. 2011;59:1412–1420.
   PubMed Web of Science ®Google Scholar
• Hayes D. Recent developments in antidepressant therapy in special populations. Am J Managed Care. 2004;10:S179–S185.
   Google Scholar
• Rabheru K. Special issues in the management of depression in older patients. Can J Psychiatry. 2004;49:41S–50S.
   PubMedGoogle Scholar
• Emslie G, Judge R. Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatr Scand Suppl. 2000;403:26–34.
   PubMedGoogle Scholar
• Schneider LS. Pharmacologic considerations in the treatment of late-life depression. Am J Geriatr Psychiatry. 1996;4(S1):S51–S65.
   Google Scholar
• Debatista C, Schatzberg AF. An algorithm for the treatment of depression and its subtypes. Psychiatr Ann. 1994;24:341–347.
   Web of Science ®Google Scholar
• Alamo C, López-Muñoz F, García-García P, et al. Risk-benefit analysis of antidepressant drug treatment in the elderly. Psychogeriatrics. 2014;14:261–268.
   PubMed Web of Science ®Google Scholar
• Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet. 2000;38:271–290.
   PubMed Web of Science ®Google Scholar
• The Human Cytochrome P450 (CYP) Allele Nomenclature Database. [cited 2016 Mar 18]. Available from: http://www.cypalleles.ki.se/last
   Google Scholar
• Anantharaju A, Feller A, Chedid A. Aging liver. A review. Gerontology. 2002;48:343–353.
   PubMed Web of Science ®Google Scholar
• Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003;38:843–853.
   PubMed Web of Science ®Google Scholar
• Lotrich FE, Pollock BG. Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol. 2005;45:1106–1122.
   PubMed Web of Science ®Google Scholar
• Sotaniemi EA, Lumme P, Arvela P, et al. Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in man. Therapie. 1994;51:363–366.
   Web of Science ®Google Scholar
• DeVane CL, Pollock BG. Pharmacokinetic considerations of antidepressant use in the elderly. J Clin Psychiatry. 1999;60:38–44.
   PubMed Web of Science ®Google Scholar
• Doogue MP, Polasek TM. Drug dosing in renal disease. Clin Biochem Rev. 2011;32:69–73.
   PubMedGoogle Scholar
• Boyce RD, Handler SM, Karp JF, et al. Age-related changes in antidepressant pharmacokinetics and potential drug-drug interactions: a comparison of evidence-based literature and package insert information. Am J Geriatr Pharmacother. 2012;10(2):139–150.
   PubMedGoogle Scholar
• Patki KC, von Moltke LL, Harmatz JS, et al. Effect of age on in vitro triazolam biotransformation in male human liver microsomes. J Pharmacol Exp Ther. 2004;308:874–879.
   PubMed Web of Science ®Google Scholar
• Trifirò G, Spina E. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. Curr Drug Metab. 2011;12:611–620.
   PubMed Web of Science ®Google Scholar
• Dickstein DL, Kabaso D, Rocher AB, et al. Changes in the structural complexity of the aged brain. Aging Cell. 2007;6:275–284.
   PubMed Web of Science ®Google Scholar
• Glassmann AH. Cardiovascular effects of antidepressant drugs: updated. Int Clin Psychopharmacol. 1998;13:25–30.
   Web of Science ®Google Scholar
• Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108:2–8.
   PubMed Web of Science ®Google Scholar
• Tata LJ, West J, Smith C, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91:465–471.
   PubMed Web of Science ®Google Scholar
• Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des. 2004;10:2463–2475.
   PubMed Web of Science ®Google Scholar
• Blanchette CM, Simoni-Wastila L, Zuckerman IH, et al. A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population. Ann Epidemiol. 2008;18:316–321.
   PubMed Web of Science ®Google Scholar
• Taylor D. Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. Acta Psychiatr Scand. 2008;118:434–442.
   PubMed Web of Science ®Google Scholar
• Schlienger RG, Fischer LM, Jick H, et al. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf. 2004;27:1157–1165.
   PubMed Web of Science ®Google Scholar
• Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62(Suppl 21):11–14.
   PubMed Web of Science ®Google Scholar
• Niranjan K, Nasim A. Hyponatraemia: removing the risk in the elderly. Geriatr Med. 2005;35:17–21.
   Google Scholar
• Mannesse CK, Jansen PA, Van Marum RJ, et al. Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study. Maturitas. 2013;76:357–363.
   PubMed Web of Science ®Google Scholar
• van Walraven C, Mamdani MM, Wells PS, et al. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ. 2001;323:655–658.
   PubMed Web of Science ®Google Scholar
• Pahor M, Guralnik JM, Salive ME, et al. Physical activity and risk of severe gastrointestinal hemorrhage in older persons. Jama. 1994;272:595–599.
   PubMed Web of Science ®Google Scholar
• Blatchford O, Davidson LA, Murray WR, et al. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. Bmj. 1997;315:510–514.
   PubMed Web of Science ®Google Scholar
• Verdel BM, Souverein PC, Egberts TC, et al. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone. 2010;47:604–609.
   PubMed Web of Science ®Google Scholar
• Sansone RA, Sansone LA. SSRIs: bad to the bone? Innov Clin Neurosci. 2012;9:42–47.
   Google Scholar
• Rabenda V, Nicolet D, Beaudart C, et al. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int. 2013;24:121–137.
   PubMed Web of Science ®Google Scholar
• Cytochrome P450 Drug Interactions Table. [cited 2016 Mar 18]. Available from: http://www.thblack.com/links/RSD/8_drug_interactions_table.pdf
   Google Scholar
• P450 Drug Interaction Table. [cited 2016 Mar 18]. Available from: http://medicine.iupui.edu/clinpharm/ddis/main-table/
   Google Scholar
• Madhusoodanan S, Velama U, Parmar J, et al. A current review of cytochrome P450 interactions of psychotropic drugs. Ann Clin Psychiatry. 2014;26:120–138.
   PubMed Web of Science ®Google Scholar
• Drug Interaction Checker. [cited 2016 Mar 18]. http://reference.medscape.com/drug-interactionchecker
   Google Scholar
• Drug Interactions Checker. [cited 2016 Mar 18]. Available from: http://www.drugs.com/drug_interactions.html
   Google Scholar
• Drug Interaction Checker. [cited 2016 Mar 18]. Available from: http://www.hep-druginteractions.org/checker
   Google Scholar
• Obreli Neto PR, Nobili A, De Lyra DP Jr, et al. Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. J Pharm Pharm Sci. 2012;15:332–343.
   PubMed Web of Science ®Google Scholar
• Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol. 2012;68:1667–1676.
   PubMed Web of Science ®Google Scholar
• Dumbreck S, Flynn A, Nairn M, et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ. 2015;350:h949.
   PubMed Web of Science ®Google Scholar
• Montastruc F, Sommet A, Bondon-Guitton E, et al. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. Eur J Clin Pharmacol. 2012;68:767–775.
   PubMed Web of Science ®Google Scholar
• Spina E, de Leon J. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2014;10:721–746.
   PubMed Web of Science ®Google Scholar
• Walley T, Pirmohamed M, Proudlove C, et al. Interaction of metoprolol and fluoxetine. Lancet. 1993;341:967–968.
   PubMed Web of Science ®Google Scholar
• Caraci F, Crupi R, Drago F, et al. Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract. Curr Drug Metab. 2011;12:570–577.
   PubMed Web of Science ®Google Scholar
• Spina E, Trifirò G, Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs. 2012;26:39–67.
   PubMed Web of Science ®Google Scholar
• Spina E, Scordo MG. Clinically significant drug interactions with antidepressants in the elderly. Drugs Aging. 2002;19:299–320.
   PubMed Web of Science ®Google Scholar
• Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry. 2008;30:284–287.
   PubMed Web of Science ®Google Scholar
• Sultana J, Spina E, Trifirò G. Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety. Expert Opin Drug Metab Toxicol. 2015;11:883–892.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Sørensen HT, Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs. 2006;20:143–151.
   PubMed Web of Science ®Google Scholar
• Schalekamp T, Klungel OH, Souverein PC, et al. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med. 2008;168:180–185.
   PubMed Web of Science ®Google Scholar
• Cochran KA, Cavallari LH, Shapiro NL, et al. Bleeding incidence with concomitant use of antidepressants and warfarin. Ther Drug Monit. 2011;33:433–438.
   PubMed Web of Science ®Google Scholar
• Tansey KE, Guipponi M, Hu X, et al. Contribution of common genetic variants to antidepressant response. Biol Psychiatry. 2013;73:679–682.
   PubMed Web of Science ®Google Scholar
• Relling MV, Klein TE. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther. 2011;89:464–467.
   PubMed Web of Science ®Google Scholar
• The Pharmacogenomics Knowledgebase. [cited 2016 May 27]. Available from: https://www.pharmgkb.org/last
   Google Scholar
• Ingelman-Sundberg M, Sim SC, Gomez A, et al. Influence of cytochrome P450 polymorphism on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther. 2007;116:496–526.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138:103–141.
   PubMed Web of Science ®Google Scholar
• Hicks JK, Swen JJ, Thorn CF, et al. Clinical pharmacogenetics implementation consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther. 2013;93:402–408.
   PubMed Web of Science ®Google Scholar
• Stingl J, Viviani R. Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs. J Intern Med. 2015;277:167–177.
   PubMed Web of Science ®Google Scholar
• Swen JJ, Nijenhuis M, de Boer A, et al. Pharmacogenetics: from bench to byte—an update of guidelines. Clin Pharmacol Ther. 2011;89:662–673.
   PubMed Web of Science ®Google Scholar
• Hiemke C, Baumann P, Bergemann N, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2011. Pharmacopsychiatry. 2011;44:195–235.
   Web of Science ®Google Scholar
• Helton TK, McGrain AR, Muliira JK. A case study: inappropriate use of amitriptyline in the elderly. Geriatr Nurs. 2005;26:317–320.
   PubMed Web of Science ®Google Scholar
• Gentile G, Chiossi L, Lionetto L, et al. Pharmacogenetic insights into migraine treatment in children. Pharmacogenomics. 2014;15:1539–1550.
   PubMed Web of Science ®Google Scholar
• Hermann M, Waade RB, Molden E. Therapeutic drug monitoring of selective serotonin reuptake inhibitors in elderly patients. Ther Drug Monit. 2015;37:546–549.
   PubMed Web of Science ®Google Scholar
• Winner JG, Carhart JM, Altar CA, et al. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation. Curr Med Res Opin. 2015;31:1633–1643.
   PubMed Web of Science ®Google Scholar